GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Cyclically Adjusted PS Ratio

Harbin Pharmaceutical Group Co (SHSE:600664) Cyclically Adjusted PS Ratio : 0.49 (As of Jun. 13, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Cyclically Adjusted PS Ratio?

As of today (2024-06-13), Harbin Pharmaceutical Group Co's current share price is ¥2.78. Harbin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥5.71. Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is 0.49.

The historical rank and industry rank for Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:600664' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.37   Med: 0.63   Max: 1.91
Current: 0.49

During the past years, Harbin Pharmaceutical Group Co's highest Cyclically Adjusted PS Ratio was 1.91. The lowest was 0.37. And the median was 0.63.

SHSE:600664's Cyclically Adjusted PS Ratio is ranked better than
86.29% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.055 vs SHSE:600664: 0.49

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Harbin Pharmaceutical Group Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥1.641. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥5.71 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Harbin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.49 0.57 0.50 0.58

Harbin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.56 0.59 0.58 0.52

Competitive Comparison of Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.



Harbin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.78/5.71
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harbin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Harbin Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.641/115.2271*115.2271
=1.641

Current CPI (Mar. 2024) = 115.2271.

Harbin Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.623 98.200 1.904
201409 1.577 98.900 1.837
201412 1.455 99.000 1.693
201503 1.619 99.900 1.867
201506 2.142 99.500 2.481
201509 1.369 100.500 1.570
201512 1.269 100.600 1.454
201603 1.418 102.200 1.599
201606 1.401 101.400 1.592
201609 1.272 102.400 1.431
201612 1.485 102.600 1.668
201703 1.326 103.200 1.481
201706 1.169 103.100 1.307
201709 1.199 104.100 1.327
201712 1.041 104.500 1.148
201803 1.223 105.300 1.338
201806 0.975 104.900 1.071
201809 0.957 106.600 1.034
201812 1.195 106.500 1.293
201903 1.105 107.700 1.182
201906 1.565 107.700 1.674
201909 1.373 109.800 1.441
201912 0.921 111.200 0.954
202003 0.942 112.300 0.967
202006 0.897 110.400 0.936
202009 0.991 111.700 1.022
202012 1.253 111.500 1.295
202103 1.079 112.662 1.104
202106 1.612 111.769 1.662
202109 1.193 112.215 1.225
202112 1.179 113.108 1.201
202203 1.328 114.335 1.338
202206 1.300 114.558 1.308
202209 1.216 115.339 1.215
202212 1.518 115.116 1.519
202303 1.607 115.116 1.609
202306 1.359 114.558 1.367
202309 1.856 115.339 1.854
202312 1.513 114.781 1.519
202403 1.641 115.227 1.641

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Harbin Pharmaceutical Group Co  (SHSE:600664) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Harbin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Lin Guo Ren senior management
Wang Hai Sheng senior management
Liu Bo senior management
Meng Xiao Dong senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Wei Shuang Ying senior management
Zhou Xing senior management
Bian Ke Supervisors
Sha Mei senior management
Jian Shi Hui Zhu Xi Supervisors
Wang Zhi Fu Supervisors
Jiang Lu Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines